Composition
- Active ingredients
- TRANDOLAPRIL 1MG; VERAPAMIL HYDROCHLORIDE 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- TRANDOLAPRIL 1MG; VERAPAMIL HYDROCHLORIDE 240MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet, extended releaseThis page
- TRANDOLAPRIL 2MG; VERAPAMIL HYDROCHLORIDE 180MG · Tablet, extended releaseNDA020591-001 · Discontinued
- TRANDOLAPRIL 2MG; VERAPAMIL HYDROCHLORIDE 240MG · Tablet, extended releaseNDA020591-004 · Discontinued
- TRANDOLAPRIL 4MG; VERAPAMIL HYDROCHLORIDE 240MG · Tablet, extended releaseNDA020591-002 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020591.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Tarka
- Active substance
- trandolapril
- Route
- Oral
- Dosage form
- Tablet, extended release
- Applicant
- Abbvie
- Status
- Discontinued
- FDA approval
- 22 Oct 1996
- Application
- NDA020591-003